
KLOW Blend
Dosage80mg
Rp 3.190.000per vial
Cold-chain delivery to your door around Bali. Pens and bacteriostatic water available, just ask.
- Class
- Peptide blend: GHK-Cu + KPV + BPC-157 + TB-500
Also known as KLOW
Little or no formal trial data. What's known comes mostly from real-world community use.
No studies on the blend as a combination; component evidence only (see component records). Effects are extrapolated from the individual peptides.
About this peptide
KLOW is the GLOW blend with KPV added, putting four peptides in one vial: GHK-Cu for skin and collagen, BPC-157 and TB-500 for recovery, and KPV for anti-inflammatory research. It is aimed at people who want skin, recovery and an inflammation angle in a single preparation. The research is on each peptide individually, not on this four-way combination. Supplied as a freeze-dried powder for research use.
What it does
Researched as an all-in-one skin, recovery and anti-inflammatory combination, extending GLOW with KPV's gut-and-skin anti-inflammatory angle. The aesthetics-and-recovery crowd who also want an inflammation lever run KLOW for the broadest single-vial coverage, chasing skin, repair and calmer inflammation at once. The widest of our recovery blends.
What to expect
Week 1
Blend not trialled as a combination; the arc below is composed from each peptide's own timeline. GHK-Cu: PIP dominant; subtle recovery feel; KPV: mild injection-site redness/a firm lump in ~25-30% (community); some early self-reported calm; BPC-157: Subtle effects; some gut users report rapid symptom relief; mild euphoria/calm or rarely fatigue/irritability; TB-500: No self-reported benefit; mild head-pressure/lethargy and injection-site reactions reported (community)
Weeks 2-4
GHK-Cu: Early skin glow / hydration; possible early hair shed-stabilise; KPV: most reported gut-comfort and skin-clarity changes (community); BPC-157: Most-common window for tendon/joint improvement, inflammation pain reduction, gut symptom improvement; mobility before structural change; TB-500: Anecdotal joint/tendon improvement; loading phase
Weeks 4-12
GHK-Cu: Skin texture/firmness changes; scar maturation; joint comfort (stacked); KPV: reported plateau; typical cycle-off point; BPC-157: Tissue-level remodeling; chronic tendinopathies most likely to improve here; community standard cycle ends ~8 weeks; TB-500: Maintenance; gains tend to plateau; stacked BPC-157 effects reported additive
Long term
GHK-Cu: Hair density plateau (Lee 2016 6-month read-out); ongoing collagen remodelling; chronic-use safety surveillance (copper accumulation) becomes the; KPV: no human safety data; preclinical signal in CAC model is protective not harmful; BPC-157: No human safety data beyond 12 months; heuristic cycle 4-8 on, 4-8 off; do not run continuously over 12 weeks; TB-500: No published human chronic-dosing data; community cycles 8 on / 4-8 off
A rough guide drawn from research and community reports. Individual results vary and nothing here is a promise.
Reported effects
Reported benefits
Side effects & cautions
Key points
Suits people who want the broadest single-vial coverage across skin, recovery and inflammation research, typically the aesthetics-and-recovery crowd who also value the gut and anti-inflammatory angle. A fit for those comfortable that each of the four components is studied on its own, not as a blend. If you only want one goal, a single peptide is cleaner.
Four separate peptides: GHK-Cu signals collagen and skin remodelling; BPC-157 and TB-500 support tissue repair; KPV, an alpha-MSH fragment, dampens inflammatory signalling in research models. The blend brings all four into one preparation.
Because the blend has not been studied as a combination, its combined effects and safety are not established; the evidence applies to the individual peptides, several of which are mostly preclinical. Reviews note caution with blood-vessel-growth-promoting compounds where a tumour may be present. Purity and correct reconstitution matter, and a Certificate of Analysis is shared where our supplier provides one.
Supplied as one freeze-dried vial containing all four peptides. Reconstitute with bacteriostatic water to your required concentration, then refrigerate at 2-8°C and keep out of light, as the copper-peptide component is light-sensitive. We can reconstitute to spec for you as a paid service, or fill a pen.
- Blood pressure
- No effect reported in available research or community use
- Heart rate
- No effect reported in available research or community use
- Blood sugar
- No effect reported in available research or community use
- IGF-1
- May reduce IGF-1 (a growth factor) levels, though less significantly than other pharmacological factors.
What studies and users commonly report happening to these markers. Research context only, not medical advice.
Questions about KLOW Blend
KLOW is the GLOW blend (GHK-Cu, BPC-157, TB-500) with KPV added for its anti-inflammatory research. As with GLOW, the research is on the components individually, not the blend.
We are not aware of published studies on this specific combination, so we describe what each component is studied for and are clear the blend itself is not established.
Evidence
- Pickart, The human tri-peptide GHK and tissue remodeling, J Biomater Sci Polym Ed 2008
- Dalmasso et al., KPV reduces intestinal inflammation, Gastroenterology 2008
- Staresinic et al., BPC-157 accelerates Achilles tendon healing, J Orthop Res 2003
- Sosne et al., Thymosin beta-4 promotes corneal wound healing, Exp Eye Res 2002
Further reading
Want to go deeper? We've written up the research on this.
Sourcing
Sourced carefully from vetted suppliers. Where a Certificate of Analysis is available we share it on request, and we'll always tell you what we have for your batch.
For Research Use Only
Sold strictly for laboratory and research purposes. Not for human or veterinary use, not a medicine, and not for diagnostic or therapeutic application.
Blends

GLOW Blend
70mg